Successful treatment of generalized pustular psoriasis during pregnancy with secukinumab in a patient hypersensitive to spesolimab: a case report
Our findings provide evidence that secukinumab is an effective and safe treatment option for GPP during pregnancy.
Authors
- Tao Yu (ORCID: https://orcid.org/0000-0003-2030-7870)
- Youyong Li (ORCID: https://orcid.org/0000-0002-5248-2756)
- Gang‐Ding Peng (ORCID: https://orcid.org/0000-0001-7984-8925)
- Shuang Zhang (ORCID: https://orcid.org/0000-0002-7367-4917)
- Chengcheng Liao (ORCID: https://orcid.org/0000-0002-8283-6316)
- Jiaxin Luo
- Yun Liang Zhang (ORCID: https://orcid.org/0000-0002-5060-1213)
- Hongwei Zhang (ORCID: https://orcid.org/0000-0001-6378-4883)
- Xia Li (ORCID: https://orcid.org/0000-0001-7236-0855)
- Jie Xiang (ORCID: https://orcid.org/0000-0002-8975-7987)
- Xinyi Nie (ORCID: https://orcid.org/0009-0002-0783-3198)
- Liping Luo
Institutions
- Novartis (Switzerland) (CH)
- Yunnan University (CN)
- Novartis (China) (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1080/09546634.2025.2474495
- Citations
- 3
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 5.64